Cora Henwood

Cora has more than 30 years’ experience in pharma, researching and developing biopharmaceuticals, with specific expertise in downstream process (purification) development and in managing and leading technical project teams.

After graduating from the University of Warwick, Cora worked at GlaxoSmithKline in R&D before moving into process development and later into technical project management. Cora has been working as a biopharmaceutical development consultant since 2009. Cora understands the perspective of scientists in both research and development so is well placed to manage the transition of projects from one to the other.  Working for GlaxoSmithKline and legacy organisations Cora has coordinated and monitored the activities leading from bench to clinic for 7 products including monoclonal antibody therapeutics and vaccines.  She is very familiar with product development activities & their dependencies, so is keenly aware of the many pitfalls that can occur. She therefore knows the importance of risk control including contingency planning.  Cora has a proven track record in partnered joint product development teams and in working effectively with external service providers. 

Cora’s key expertise within CMC is process development and scale-up of biopharmaceutical products.  She is also very experienced in the GMP manufacturing of biologicals together with the selection and management of contract manufacturing organisations.